微信公众号

官网二维码

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (6): 715-721.doi: 10.3969/j.issn.1674-5671.2025.06.09

• 论著 • 上一篇    下一篇

 美雌醇通过促进AGK表达增强CD8+ T细胞效应功能

  


  • 出版日期:2025-12-25 发布日期:2026-02-02
  • 通讯作者: 徐小洁 E-mail:miraclexxj@126.com; 车永胜 E-mail:ysche@imb.cams.cn
  • 基金资助:
    国家重点研发计划项目(2023YFA0914900);国家自然科学基金青年科学基金项目(82404651);北京市自然科学基金?昌平创新联合基金项目(L234042)

Mestranol enhances CD8+ T cell effector functions by promoting expression of AGK


  • Online:2025-12-25 Published:2026-02-02

摘要: 目的 探究美雌醇(Mestranol,Mes)对酰基甘油激酶(acylglycerol kinase,AGK)的转录激活潜力及其增强CD8+ T细胞效应功能的作用。方法 利用公共数据库分析AGK与CD8+ T细胞效应功能基因及肿瘤微环境中CD8+ T细胞浸润水平的相关性。通过qPCR和Western blot实验检测美雌醇对AGK mRNA和蛋白质表达水平以及对AGK下游信号通路激活的影响。CCK⁃8法测定美雌醇的半数抑制浓度(half maximal inhibitory concentration,IC50)。电穿孔法将AGK过表达质粒导入人T淋巴细胞白血病细胞Jurkat和CD8+ T细胞,荧光素酶报告基因检测评估美雌醇对AGK启动子转录活性的影响。ELISA法检测AGK过表达后CD8+ T细胞分泌干扰素⁃γ(interferon⁃γ, IFN⁃γ)和肿瘤坏死因子⁃α(tumor necrosis factor⁃α, TNF⁃α)的浓度及美雌醇对其的影响。流式细胞术检测美雌醇对CD8+ T细胞体外杀伤能力的影响。结果 公共数据库分析显示,AGK表达与促进CD8+ T细胞效应功能的基因呈正相关,与抑制功能的基因呈负相关,且与多种肿瘤微环境中的CD8+ T细胞浸润水平呈正相关(均P<0.05)。美雌醇的IC50为36 μmol/L,不同浓度的美雌醇均可上调Jurkat细胞中AGK的mRNA和蛋白表达(均P<0.01),且呈剂量依赖性。荧光素酶报告基因检测实验显示,美雌醇显著增强AGK启动子的转录活性(P<0.001)。美雌醇可提高AKT蛋白在Ser473位点的磷酸化水平,且增强CD8+ T细胞分泌IFN⁃γ和TNF⁃α(均P<0.001)以及体外杀伤肿瘤的能力(P<0.01)。结论 美雌醇通过增强AGK启动子的转录活性上调AGK表达,增强CD8+ T细胞的效应功能,为基于AGK靶点的肿瘤免疫治疗提供了新思路。

关键词: 美雌醇, 酰基甘油激酶, CD8+ T细胞, 肿瘤免疫

Abstract: Objective To investigate the transcriptional activation potential of Mestranol (Mes) on acylglycerol Kinase (AGK) and its role in enhancing CD8+ T cell effector function. Methods Public databases were utilized to analyze the correlation between AGK expression and CD8+ T cell effector function genes, and its association with CD8+ T cell infiltration levels across the tumor microenvironments. The effects of Mestranol on AGK mRNA and protein expression levels, as well as on the activation of the AGK downstream signaling pathway were assessed using quantitative PCR (qPCR) and Western blot. The half maximal inhibitory concentration (IC50) of Mestranol was determined using the CCK⁃8 assay. An AGK overexpression plasmid was transfected into human T lymphocyte leukemia Jurkat cells and CD8⁺ T cells by electroporation, and a luciferase reporter gene assay was employed to examine the impact of Mestranol on AGK promoter transcriptional activity. Enzyme⁃linked immunosorbent assay (ELISA) was used to quantify the levels of  interferon⁃γ (IFN⁃γ) and tumor necrosis factor⁃α (TNF⁃α) secreted by CD8+ T cells under following AGK overexpression, along with Mestranol's effects on these parameters. The effects of Mestranol on the cytotoxic activity of CD8+ T cells was assessed in vitro using flow cytometry.  Results Public databases analysis revealed that AGK expression was significantly positively correlated with CD8+T cell effector function genes, negatively correlated with inhibitory function genes, and positively associated with CD8+ T cell infiltration levels in various tumor microenvironments (all P<0.05). The IC50 of Mestranol was 36 μmol/L. Mestranol significantly upregulated AGK expression at both mRNA and protein levels in Jurkat cells in a dose⁃dependent manner across various concentrations (all P<0.01). Furthermore, luciferase reporter assays demonstrated that Mestranol significantly enhanced the transcriptional activity of the AGK promoter(P<0.001). Mestranol elevated the phosphorylation levels of AKT protein at Ser473, enhanced the secretion of IFN⁃γ and TNF⁃α in treated CD8⁺T cells (all P<0.001), and increased their tumor⁃killing capacity in vitro (P<0.01).  Conclusions Mestranol up⁃regulates AGK expression by enhancing the transcriptional activity of the AGK promoter, thereby augmenting CD8+ T cell effector function, which provides a new insight for tumor immunotherapy targeting AGK.

Key words: Mestranol, Acylglycerol kinase, CD8+ T cell, Tumor immunity

中图分类号: 

  •